메뉴 건너뛰기




Volumn 5, Issue 8, 2008, Pages 1200-1204

The use of nonhuman primate models in HIV vaccine development

(17)  Morgan, Cecilia a   Marthas, Marta b   Miller, Christopher c   Duerr, Ann a   Cheng Mayer, Cecilia d   Desrosiers, Ronald e   Flores, Jorge f   Haigwood, Nancy g   Hu, Shiu Lok h   Johnson, R Paul e   Lifson, Jeffrey i   Montefiori, David j   Moore, John k   Robert Guroff, Marjorie l   Robinson, Harriet m   Self, Steven a   Corey, Lawrence a  


Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

EID: 50949114906     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050173     Document Type: Review
Times cited : (87)

References (15)
  • 1
    • 2342463654 scopus 로고    scopus 로고
    • Prospects for an AIDS vaccine
    • Desrosiers RC (2004) Prospects for an AIDS vaccine. Nat Med 10: 221-223.
    • (2004) Nat Med , vol.10 , pp. 221-223
    • Desrosiers, R.C.1
  • 2
    • 0036129320 scopus 로고    scopus 로고
    • AIDS vaccine models: Challenging challenge viruses
    • Feinberg MB, Moore JP (2002) AIDS vaccine models: Challenging challenge viruses. Nat Med 8: 207-210.
    • (2002) Nat Med , vol.8 , pp. 207-210
    • Feinberg, M.B.1    Moore, J.P.2
  • 3
    • 13644270930 scopus 로고    scopus 로고
    • Predictive value of primate models for AIDS
    • Haigwood NL (2004) Predictive value of primate models for AIDS. AIDS Rev 6: 187-198.
    • (2004) AIDS Rev , vol.6 , pp. 187-198
    • Haigwood, N.L.1
  • 4
    • 22144469118 scopus 로고    scopus 로고
    • Non-human primate models for AIDS vaccine research
    • Hu SL (2005) Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 5: 193-201.
    • (2005) Curr Drug Targets Infect Disord , vol.5 , pp. 193-201
    • Hu, S.L.1
  • 5
    • 33745789917 scopus 로고    scopus 로고
    • HIV pathogenesis and vaccine development
    • Johnson RP (2006) HIV pathogenesis and vaccine development. Top HIV Med 14: 8-15.
    • (2006) Top HIV Med , vol.14 , pp. 8-15
    • Johnson, R.P.1
  • 7
    • 33845207660 scopus 로고    scopus 로고
    • Progress and obstacles in the development of an AIDS vaccine
    • Letvin NL (2006) Progress and obstacles in the development of an AIDS vaccine. Nat Rev Immunol 6: 930-939.
    • (2006) Nat Rev Immunol , vol.6 , pp. 930-939
    • Letvin, N.L.1
  • 8
    • 0037122772 scopus 로고    scopus 로고
    • One step forwards, one step back
    • Lifson JD, Martin MA (2002) One step forwards, one step back. Nature 415: 272-273.
    • (2002) Nature , vol.415 , pp. 272-273
    • Lifson, J.D.1    Martin, M.A.2
  • 9
    • 4344702857 scopus 로고    scopus 로고
    • A call for replicating vector prime-protein boost strategies in HIV vaccine design
    • Malkevitch NV, Robert-Guroff M (2004) A call for replicating vector prime-protein boost strategies in HIV vaccine design. Expert Rev Vaccines 3: S105-S117.
    • (2004) Expert Rev Vaccines , vol.3
    • Malkevitch, N.V.1    Robert-Guroff, M.2
  • 10
    • 17644419950 scopus 로고    scopus 로고
    • T cell vaccines for microbial infections
    • Robinson HL, Amara RR (2005) T cell vaccines for microbial infections. Nat Med 11: S25-S32.
    • (2005) Nat Med , vol.11
    • Robinson, H.L.1    Amara, R.R.2
  • 11
    • 0037122719 scopus 로고    scopus 로고
    • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
    • Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, et al. (2002) Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415: 331-335.
    • (2002) Nature , vol.415 , pp. 331-335
    • Shiver, J.W.1    Fu, T.M.2    Chen, L.3    Casimiro, D.R.4    Davies, M.E.5
  • 12
    • 29244455769 scopus 로고    scopus 로고
    • Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
    • Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, et al. (2005) Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J Virol 79: 15547-15555.
    • (2005) J Virol , vol.79 , pp. 15547-15555
    • Casimiro, D.R.1    Wang, F.2    Schleif, W.A.3    Liang, X.4    Zhang, Z.Q.5
  • 13
    • 33744902339 scopus 로고    scopus 로고
    • Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
    • Wilson NA, Reed J, Napoe GS, Piaskowski S, Szymanski A, et al. (2006) Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 80: 5875-5885.
    • (2006) J Virol , vol.80 , pp. 5875-5885
    • Wilson, N.A.1    Reed, J.2    Napoe, G.S.3    Piaskowski, S.4    Szymanski, A.5
  • 14
    • 0032849066 scopus 로고    scopus 로고
    • Protection by live, attenuated simian immunodeficiency virus against heterologous challenge
    • Wyand MS, Manson K, Montefiori DC, Lifson JD, Johnson RP, et al. (1999) Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J Virol 73: 8356-8363.
    • (1999) J Virol , vol.73 , pp. 8356-8363
    • Wyand, M.S.1    Manson, K.2    Montefiori, D.C.3    Lifson, J.D.4    Johnson, R.P.5
  • 15
    • 42049115708 scopus 로고    scopus 로고
    • Efficacy results from the Step Study (Merck V520 Protocol 023/HVTN 502)-A phase II test-of-concept trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent vaccine
    • abstract 88LB, 3-6 February, Boston, Massachusetts, United States of America. Available:, Accessed 10 July 2008
    • Robertson M, Mehron-a D, Fitzgerald D, Duerr A, Casimiro D, et al. (2008) Efficacy results from the Step Study (Merck V520 Protocol 023/HVTN 502)-A phase II test-of-concept trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent vaccine [abstract 88LB]. 15th Conference on Retroviruses and Opportunistic Infections; 3-6 February 2008; Boston, Massachusetts, United States of America. Available: http://www.hvtn.org/science/step_buch.html. Accessed 10 July 2008.
    • (2008) 15th Conference on Retroviruses and Opportunistic Infections
    • Robertson, M.1    Mehron-a, D.2    Fitzgerald, D.3    Duerr, A.4    Casimiro, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.